VANCOUVER, British Columbia & MUMBAI, India--(BUSINESS WIRE)--SaNOtize Research and Development Corp. and Indian company, Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical ...

SaNOtize has raised a $24 million series B round, giving it the cash to fund its ongoing phase 3 COVID-19 prevention trial and other research into its nitric oxide nasal spray (NONS). The ...

VANCOUVER, British Columbia & TEL AVIV, Israel--(BUSINESS WIRE)--Biotech company SaNOtize Research & Development Corp., (SaNOtize) today announced that it has received interim approval to sell its ...

Although Israel approved Enovid as a medical device with a claim to protect from viruses, Phase II clinical trials in the United Kingdom found statistically significant evidence that the spray can ...

OurCrowd portfolio company SaNOtize Research & Development Corp. has received interim approval to sell its COVID-19 treatment Nitric Oxide Nasal Spray (NONS). The spray is said to protect users from ...

There are currently zero authorized or approved preventative COVID therapies in the U.S. but Canadian biotech SaNOtize wants to change that, charting plans to move a nasal spray into a phase 3 study ...

U.K. physicians have begun clinical development of a nasal spray designed to prevent infection with the coronavirus and treat mild to moderate cases of COVID-19. The spray delivers nitric oxide into ...

Israel and New Zealand have given interim approval for the sale of biotech firm SaNOtize Research and Development's Nitric Oxide Nasal Spray (NONS) which could help prevent transmission of the ...

A novel nasal spray treatment appears to show promise in quickly clearing the coronavirus that causes covid-19 from our nostrils. In a recent Phase III trial in India, the spray was found to ...

OurCrowd portfolio company SaNOtize says that a UK clinical trial has delivered solid results as COVID-19 treatment. A self-administered nasal spray is said to reduce the viral load by more than 95% ...

JERUSALEM/WELLINGTON (Reuters) - Israel and New Zealand have given interim approval for the sale of biotech firm SaNOtize Research and Development's Nitric Oxide Nasal Spray (NONS) which could help ...